miltefosine and elacridar

miltefosine has been researched along with elacridar in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Barron, D; Bavchvarov, BI; Castanys, S; Cortés-Selva, F; Costi, MP; Di Pietro, A; Gamarro, F; Maitrejean, M; Muñoz-Martínez, F; Parodi-Talice, A; Pérez-Victoria, FJ; Pérez-Victoria, JM	1

Other Studies

2 other study(ies) available for miltefosine and elacridar

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9 Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Membrane; Chlorocebus aethiops; Cytosol; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Humans; Leishmania; Mice; NIH 3T3 Cells; Phosphorylcholine; Protein Structure, Tertiary; Quinolines; Tetrahydroisoquinolines; Vero Cells	2006

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux.

Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9

Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Membrane; Chlorocebus aethiops; Cytosol; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Humans; Leishmania; Mice; NIH 3T3 Cells; Phosphorylcholine; Protein Structure, Tertiary; Quinolines; Tetrahydroisoquinolines; Vero Cells

2006